Metalloproteinases. Structure and function;Metaloproteinazy MMP. Struktura i funkcja

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 62, Issue , 2008, Pages 328-336

  Lipka, Dominik ^a   Boratyński, Janusz ^a,b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b JAN DLUGOSZ UNIVERSITY   (Poland)

Author keywords

Autoimmunological diseases; Cancer; Cell migration; Collagenases; Extracellular matrix; Metalloproteinases; MMP; Proteolitical enzymes

Indexed keywords

4 AMINOBENZOIC ACID; AMINOBENZOIC ACID, CALCIUM PANTOTHENATE, CHLOROQUINE, QUINACRINE, PYRIDOXINE DRUG COMBINATION; CHLOROQUINE; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN; MEPACRINE; PANTOTHENIC ACID; PYRIDOXINE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANGIOGENESIS; ANIMAL; APOPTOSIS; ARTHRITIS; AUTOIMMUNE DISEASE; CELL MOTION; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; DRUG ANTAGONISM; DRUG COMBINATION; ENZYME ACTIVATION; ENZYMOLOGY; EXTRACELLULAR MATRIX; HUMAN; METABOLISM; NEOPLASM; PHYSIOLOGY; REVIEW;

4-AMINOBENZOIC ACID; ANIMALS; APOPTOSIS; ARTHRITIS; AUTOIMMUNE DISEASES; CELL MOVEMENT; CHLOROQUINE; DRUG COMBINATIONS; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MODELS, MOLECULAR; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; PANTOTHENIC ACID; PYRIDOXINE; QUINACRINE; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 79959452715     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Ahonen M., Poukkula M., Baker A.H., Kashiwagi M., Nagase H., Eriksson J.E., Kähäri V.M.: Tissue inhibitor of metalloproteinase-3 induces apoptosis in melanoma cells by stabilization of death receptors. Oncogene, 2003; 22: 2121-2134
2. Aimes R.T., Quigley J.P.: Matrix metalloproteinase-2 is an interstitial collagenase: inhibitor-free enzyme catalyzes the cleavage of collage fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J. Biol. Chem., 1995; 270: 5872-5876
3. Ala-aho R., Kähäri V.M.: Collagenases in cancer. Biochimie., 2005; 87: 273-286
4. Allan J.A., Docherty A.J., Barker P.J., Huskisson N.S., Reynolds J.J., Murphy G.: Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem J. 1995; 309: 299-306
5. Bode W., Fernandez-Catalan C., Tschesche H., Grams F., Nagase H., Maskos K.: Structural properties of matrix metalloproteinases. Cell. Mol. Life Sci., 1999; 55: 639-652
6. Cawston T.E., Mercer E.: Preferential binding of collagenase to a2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases. FEBS Lett., 1986; 209: 9-12
7. Gohlke U. Gomis-Rüth F.X, Crabbe T., Murphy G., Docherty A.J., Bode W.: The C-terminal (haemopexin-like) domain structure of human gelatinaseA (MMP-2): structural implications for its function. FEBS Lett., 1996; 378: 126-130
8. Guedez L., Courtemanch L., Stetler-Stevenson M.: Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood, 1998; 92: 1342-1349
9. Handsley M.M., Edwards D.R,: Metalloproteinases and their inhibitors in tumor angiogenesis., Int. J. Cancer., 2005; 115: 849-860
10. Herman M.P., Sukhova G.K., Kisiel W., Foster D., Kehry M.R., Libby P., Schonbeck U.: Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis. J. Clin. Invest., 2001; 107: 1117-1126
11. Hrabec E., Naduk J., Stręk M., Hrabec Z.: Kolagenazy typu IV (MMP-2 i MMP-9) i ich substraty-białka macierzy pozakomórkowej, hormony, cytokin, hemokiny i ich receptory. Post. Biochem., 2007; 53: 37-45
12. Itoh T., Ikeda T., Gomi H., Nakao S., Suzuki T., Itohara S.: Unaltered secretion of amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J. Biol. Chem., 1997; 272: 22389-22392
13. Kolb C., Mauch S., Peter H.H., Krawinkel U., Sedlacek R.: The matrix metalloproteinase RASI-1 is expressed in synovial blood vessels of a rheumatoid arthritis patient. Immunol. Lett., 1997; 57: 83-88
14. Li W., Gibson C.W., Abrams W.R., Andrews D.W., DenBesten P.K.: Reduced hydrolysis of amelogenin may result in X-linked amelogenesis imperfecta. Matrix Biol., 2001; 19: 755-760
15. Lohi J., Wilson C.L., Roby J.D., Parks W.C.: Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J. Biol. Chem., 2001; 276: 10134-10144
16. Maskos K.: Crystal structures of MMPs in complex with physiological and pharmacological inhibitors. Biochimie, 2005; 87: 249-263
17. Murphy G., Allan J.A., Willenbrock F., Cockett M.I., O'Connell J.P., Docherty A.J.: The role of the C-terminal domain in collagenase and stromelysin specificity, J. Biol. Chem., 1992; 267: 9612-9618
18. Murphy G., Houbrechts A., Cockett M.I., Williamson R.A., O'Shea M., Docherty A.J.: The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry, 1991; 30: 8097-8102
19. Nagase H.: Activation mechanisms of matrix metalloproteinases. Biol Chem., 1997; 378: 151-160
20. Pei D., Weiss S.J.: Furin-dependent intracellular activation of the human stromelysin 3 zymogen. Nature, 1995; 375: 244-247
21. Pepper M.S.: Extracellular proteolysis and angiogenesis. Thromb. Haemost., 2001; 86: 346-355
22. Ritter L.M., Garfield S.H., Thorgeirsson U.P.: Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem. Biophys. Res. Commun., 1999; 257: 494-499
23. Rundhaug J.E.: Matrix metalloproteinases and angiogenesis. J. Cell. Mol. Med., 2005; 9: 267-285
24. Shapiro S.D., Kobayashi D.K., Ley T.J.: Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem., 1993; 268: 23824-23829
25. Suzuki K., Enghild J.J., Morodomi T., Salvesen G., Nagase H.: Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry. 1990; 29: 10261-10270
26. Tam E.M., Moore T.R., Butler G.S., Overall C.M.: Characterization of the distinct collagen binding and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinaseA and MT1-MMP): The differentia roles of the MMP hemopexin C domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities, J. Biol. Chem., 2004; 279: 43336-43344
27. Uria J.A, López-Otín C.: Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res., 2000; 60: 4745-4751
28. Velasco G., Pendas A.M., Fueyo A., Knäuper V., Murphy G., López-Otín C.: Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J. Biol. Chem., 1999; 274: 4570-4576
29. Visse R., Nagase H.: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res., 2003; 92: 827-839